Carnitine Intake And Serum Levels Associate Positively With Postnatal Growth And Brain Size At Term In Very Preterm Infants

This study examined carnitine, a natural compound that plays a crucial role in how our cells produce energy, particularly in very premature infants. Researchers followed 35 babies born before 32 weeks of pregnancy at a Finnish hospital to understand how carnitine intake and blood levels affected their growth and brain development during their extended hospital stays.

The researchers tracked these infants' carnitine intake from milk feedings and measured carnitine levels in their blood at different time points - at 1 week, 5 weeks, and when they reached full-term equivalent age. They then compared these measurements to how well the babies grew (weight, length, and head size) and used MRI scans to measure actual brain size at discharge.

The results showed a clear positive relationship: babies who consumed more carnitine through their feeding and maintained higher carnitine levels in their blood experienced better growth in length and head circumference, and developed larger brains by the time they were ready to go home. This finding is significant because proper early growth and brain development in premature infants can have lasting effects on their long-term health and cognitive function.

For metabolic health, this research highlights carnitine's fundamental role in supporting cellular energy production during critical developmental periods. While this study focused on premature infants, it reinforces the importance of adequate carnitine for optimal growth and brain function. In clinical practice, this supports ensuring premature infants receive sufficient carnitine through specialized nutrition protocols, and may inform discussions about carnitine's role in supporting metabolic health throughout life.